MedicalResearch.com Interview with:
Man-tian Mi
Research Center for Nutrition and Food Safety,
Chongqing Key Laboratory of Nutrition and Food Safety,
Institute of Military Preventive Medicine,
Third Military Medical University
Chongqing China
MedicalResearch.com: What is the background for this study? What are the main findings?
Reply: Cardiovascular diseases remain the leading cause of death in industrialized societies including the United States, and the incidence is growing in developing countries (
1). In recent years, researchers have learned that the gut microbiome plays a role in the build up of plaque inside arteries, otherwise known as atherosclerosis (
2,
3). Resveratrol, a polyphenol found in red wine, is thought to have antioxidant properties that protect against conditions such as heart disease (
4). Just how resveratrol, a plant compound, does this, however, is unclear. Therefore, we sought to determine whether the anti-atherosclerosis effects of resveratrol were related to changes in the gut microbiota.
We found that resveratrol attenuated trimethylamine-N-oxide (TMAO)-induced atherosclerosis by decreasing TMAO levels and increasing hepatic bile acid (BA) neosynthesis
via gut microbiota remodeling, and the BA neosynthesis was partially mediated through the enterohepatic farnesoid X receptor-fibroblast growth factor 15 axis. These results offer new insights into the mechanisms responsible for resveratrol’s anti-atherosclerosis effects and indicate that gut microbiota may become an interesting target for pharmacological or dietary interventions to decrease the risk of developing cardiovascular diseases.